YU68299A - Preparati rastvorenog sertralina - Google Patents

Preparati rastvorenog sertralina

Info

Publication number
YU68299A
YU68299A YU68299A YU68299A YU68299A YU 68299 A YU68299 A YU 68299A YU 68299 A YU68299 A YU 68299A YU 68299 A YU68299 A YU 68299A YU 68299 A YU68299 A YU 68299A
Authority
YU
Yugoslavia
Prior art keywords
compositions
solubilized
solubilized sertraline
sertraline compositions
sertraline
Prior art date
Application number
YU68299A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Dwayne Thomas Friesen
Scott Max Herbig
Ravi Mysore Shanker
James Blair West
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU68299(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU68299A publication Critical patent/YU68299A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU68299A 1997-07-01 1998-06-15 Preparati rastvorenog sertralina YU68299A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
YU68299A true YU68299A (sh) 2002-06-19

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
YU68299A YU68299A (sh) 1997-07-01 1998-06-15 Preparati rastvorenog sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (no)
JP (1) JP2000514100A (no)
KR (1) KR100366373B1 (no)
CN (1) CN1261794A (no)
AP (1) AP1192A (no)
AR (3) AR015917A1 (no)
AU (1) AU742535B2 (no)
BG (1) BG103918A (no)
BR (1) BR9810739A (no)
CA (1) CA2290974C (no)
CO (1) CO4940495A1 (no)
DZ (1) DZ2548A1 (no)
EA (1) EA002481B1 (no)
HN (1) HN1998000102A (no)
HR (1) HRP980377A2 (no)
HU (1) HUP0002236A3 (no)
ID (1) ID23429A (no)
IL (1) IL133076A (no)
IS (1) IS5260A (no)
MA (1) MA24587A1 (no)
NO (1) NO996520L (no)
OA (1) OA11243A (no)
PA (1) PA8454301A1 (no)
PE (1) PE97199A1 (no)
PL (1) PL337804A1 (no)
SK (1) SK181099A3 (no)
TN (1) TNSN98124A1 (no)
TR (1) TR199903297T2 (no)
TW (1) TW550087B (no)
UA (1) UA67741C2 (no)
UY (1) UY25071A1 (no)
WO (1) WO1999001120A1 (no)
YU (1) YU68299A (no)
ZA (1) ZA985708B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784340B2 (en) 1999-12-23 2006-03-16 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
WO2008110268A1 (en) * 2007-03-12 2008-09-18 Dsm Ip Assets B.V. Cosmetic compositions
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EP0999829A1 (en) 2000-05-17
CO4940495A1 (es) 2000-07-24
CN1261794A (zh) 2000-08-02
DZ2548A1 (fr) 2003-02-08
CA2290974A1 (en) 1999-01-14
BR9810739A (pt) 2000-09-12
AU7544898A (en) 1999-01-25
HUP0002236A2 (hu) 2003-08-28
KR100366373B1 (ko) 2003-01-14
EA199900962A1 (ru) 2000-08-28
PA8454301A1 (es) 2000-09-29
OA11243A (en) 2003-07-24
IS5260A (is) 1999-11-19
EA002481B1 (ru) 2002-06-27
AR040280A2 (es) 2005-03-23
IL133076A0 (en) 2001-03-19
ZA985708B (en) 2000-01-10
NO996520D0 (no) 1999-12-28
TNSN98124A1 (fr) 2005-03-15
BG103918A (en) 2000-07-31
UY25071A1 (es) 2000-12-29
KR20010013365A (ko) 2001-02-26
ID23429A (id) 2000-04-20
WO1999001120A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
AP1192A (en) 2003-07-23
AU742535B2 (en) 2002-01-03
HRP980377A2 (en) 1999-04-30
AR015917A1 (es) 2001-05-30
UA67741C2 (uk) 2004-07-15
IL133076A (en) 2003-12-10
HN1998000102A (es) 1999-01-08
PE97199A1 (es) 1999-10-05
CA2290974C (en) 2004-04-27
TW550087B (en) 2003-09-01
MA24587A1 (fr) 1998-12-31
JP2000514100A (ja) 2000-10-24
NO996520L (no) 2000-02-29
TR199903297T2 (xx) 2000-07-21
HUP0002236A3 (en) 2003-12-29
PL337804A1 (en) 2000-09-11
AR040279A2 (es) 2005-03-23
SK181099A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
GB9717905D0 (en) Lipid-containing compositions and uses thereof
ZA995601B (en) Water-soluble pharmaceutical composition in an ionic complex and the use thereof.
EP1017427A4 (en) BIOCIDES COMBINED CHELATORS: MICROBIOLOGICALLY INDUCED BIOFILM TREATMENT AND CORROSION
MX9704377A (es) Uso de pramipexole como agente neuroprotector.
HUP0103267A3 (en) High-strength aqueous glyphosate concentrate and use thereof
EP0680694A3 (en) Composition of fluorescent biocides for use in aqueous systems.
AU3117397A (en) Fire-fighting agents containing polysaccharides and fluorochemical oligomeric surfactants
NZ239879A (en) Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent
AU7597898A (en) Use of isoflavonoids in the treatment or prevention of postpartum depression
YU68299A (sh) Preparati rastvorenog sertralina
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
ZA200102956B (en) Use of ophthalmic composition comprising vitamin A and Vitamin E.
AU1887399A (en) Aqueous compositions comprising complexing agents and uses therof
EP0610010A3 (en) Liquid compositions containing bleaching and / or hygienic agents having low solubility in water.
IL126185A0 (en) Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
AU2600499A (en) Methods and compositions comprising the use of blocked b-amyloid peptide
AU6519198A (en) Melaninization inhibitor, skin-care preparation, and bath agent
IL139874A0 (en) Coating agent and the use thereof
BG104825A (en) Ophthalmic solution comprising glycogen
BG104914A (en) Paroxetine maleate
MY119728A (en) Encapsulated solution dosage forms of sertraline
EP0657522A3 (en) Salt compositions and their use in functional liquids.
GB9802542D0 (en) New use
MD980129A (en) Antiherpetic remedy
PL347545A1 (en) Case-safe system